Related Experiment Video
Updated: Jan 26, 2026

06:50
Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening
Published on: September 5, 2025
429
Exploiting tumor metabolism: challenges for clinical translation
1Koch Institute for Integrative Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA. mvh@mit.edu
The Journal of Clinical Investigation
|September 4, 2013
Summary
Cancer cells have unique metabolic needs for growth and survival. Exploiting these metabolic differences offers a promising avenue for developing novel cancer therapies and patient monitoring strategies.
Area of Science:
- Biochemistry
- Oncology
- Metabolomics
Background:
- Cancer cells exhibit distinct metabolic pathways compared to normal cells, essential for nutrient assimilation and proliferation.
- Tumor cells adapt their metabolism to survive in diverse microenvironmental conditions outside of normal tissue contexts.
Discussion:
- Targeting cancer cell metabolism is a resurgent area for novel drug development.
- Understanding the specific roles of metabolic pathways in cancer is crucial for therapeutic success.
- Patient selection and response monitoring are key challenges for metabolic therapies.
Key Insights:
- Altered cancer metabolism influences tumor progression.
- Knowledge of metabolic vulnerabilities can guide the development of targeted therapies.
- Biomarker strategies are emerging to aid drug development in cancer metabolism.
Outlook:
- Further research into cancer cell metabolism will refine targeted drug development.
- Improved patient stratification and monitoring technologies will enhance the efficacy of metabolic therapies.
- Exploiting metabolic differences holds significant potential for improving patient outcomes.
Related Concept Videos
Translation
156.0K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
156.0K
Translation
17.7K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
17.7K
What is Metabolism?
131.5K
Overview
131.5K
Initiation of Translation
38.5K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
38.5K
Termination of Translation
27.5K
The large ribosomal subunit has several important structures essential to translation. These include the peptidyl transferase center (PTC) - which is the site where the peptide bond is formed - and a large, internal, water-filled tube through which the nascent polypeptide moves. This latter structure is called the Peptide Exit Tunnel, and it begins at the PTC and spans the body of the large ribosomal subunit. During translation, as the nascent polypeptide chain is synthesized, it passes through...
27.5K
Termination of Translation
6.6K
No description available
6.6K

